← Back to Clinical Trials
Recruiting NCT07849439

NCT07849439 Two-Week Stair-Climbing Exercise Snacks and Metabolic Health in Adults With Overweight or Obesity: A Pilot Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07849439
Status Recruiting
Phase —
Sponsor St. Louis University
Condition Overweight , Obesity
Study Type INTERVENTIONAL
Enrollment 12 participants
Start Date 2026-10
Primary Completion 2027-07

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 35 Years
Study Type INTERVENTIONAL
Interventions
Stair-Climbing Exercise Snacks

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 12 participants in total. It began in 2026-10 with a primary completion date of 2027-07.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This pilot study will evaluate whether brief bouts of stair climbing performed throughout the day for two weeks can improve metabolic health, cardiovascular fitness, and other health-related outcomes in adults with overweight or obesity who do not regularly exercise. Participants will complete approximately 6-8 brief stair-climbing "exercise snacks" per day for 14 days, with each bout consisting of approximately 60 total stair steps performed at a challenging but safe self-selected pace. Participants will complete baseline and post-intervention assessments at Saint Louis University. These assessments will include continuous glucose monitoring and standardized meal testing to evaluate glucose responses, as well as measures of aerobic fitness, anaerobic power, body composition, waist circumference, and muscular strength. The study will also evaluate adherence, perceived exercise intensity, and the feasibility of incorporating brief stair-climbing bouts into daily life.

Eligibility Criteria

Inclusion Criteria: * Age 18-35 years and able to provide informed consent. * Body mass index (BMI) 25.0-34.99 kg/m² and otherwise healthy, without chronic disease. * Sedentary or low-active lifestyle, defined as no regular structured exercise ≥3 days/week for ≥30 minutes per session during the past 3 months. * Access to a safe staircase that permits completion of approximately 60 total stair steps per exercise bout. Approximately 60 upward steps are preferred when available; one or more flights may be used repeatedly if needed. * No contraindications or increased-risk findings identified on the PAR-Q+ or health history screening. Exclusion Criteria: * Known cardiovascular, pulmonary, metabolic, renal, neurological, or musculoskeletal disease, or signs or symptoms suggesting increased risk during vigorous exercise, including diagnosed diabetes mellitus, cardiovascular disease, uncontrolled hypertension, chronic pulmonary disease, kidney disease, fainting or unexplained dizziness during exercise, chest pain with exertion, or severe shortness of breath with mild-to-moderate activity. * Current use of medications that may affect exercise tolerance, heart-rate response, balance, glucose metabolism, or safety during vigorous exercise, including insulin or other glucose-lowering medications, beta-blockers, anti-arrhythmic medications, systemic corticosteroids, or medications that may cause dizziness, impaired balance, or altered exercise response. * Orthopedic or joint conditions that could be aggravated by repeated stair climbing. * Allergy, intolerance, dietary restriction, or other condition preventing safe consumption of the standardized meal replacement shake. * Pregnancy or plans to become pregnant during the study period. * Any other medical or psychological condition that, in the investigator's judgment, could make adherence difficult or place the participant at risk. * Individuals currently enrolled in a course taught by the PI or other study personnel, or who are directly supervised, graded, or formally evaluated by a member of the study team.

Contact & Investigator

Central Contact

Hossein Rafiei, PhD, RD

✉ hossein.rafiei@health.slu.edu

📞 314-977-8675

Principal Investigator

Hossein Rafiei, PhD, RD

PRINCIPAL INVESTIGATOR

St. Louis University

Frequently Asked Questions

Who can join the NCT07849439 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 35 Years, studying Overweight , Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07849439 currently recruiting?

Yes, NCT07849439 is actively recruiting participants. Contact the research team at hossein.rafiei@health.slu.edu for enrollment information.

Where is the NCT07849439 trial being conducted?

This trial is being conducted at St Louis, United States.

Who is sponsoring the NCT07849439 clinical trial?

NCT07849439 is sponsored by St. Louis University. The principal investigator is Hossein Rafiei, PhD, RD at St. Louis University. The trial plans to enroll 12 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology